The Current Ratio as of November 2024 (TTM) for Prime Medicine, Inc. (PRME) is 6.50

According to Prime Medicine, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.50. This represents a change of -0.69% compared to the average of 6.54 of the last 4 quarters.

Prime Medicine, Inc. (PRME) Historical Current Ratio (quarterly & annually)

How has PRME Current Ratio performed in the past?

The mean historical Current Ratio of Prime Medicine, Inc. over the last ten years is 4.43. The current 6.50 Current Ratio has changed 14.57% with respect to the historical average. Over the past ten years (40 quarters), PRME's Current Ratio was at its highest in in the September 2021 quarter at 31.48. The Current Ratio was at its lowest in in the December 2019 quarter at 0.

Prime Medicine, Inc. (PRME) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Prime Medicine, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Prime Medicine, Inc. (PRME) Average Current Ratio

How has PRME Current Ratio performed in the past?

The current Current Ratio of Prime Medicine, Inc. (PRME) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Prime Medicine, Inc. (PRME) Current Ratio vs. Peers

How is PRME’s Current Ratio compared to its peers?

Prime Medicine, Inc.’s Current Ratio is greater than Beam Therapeutics Inc. (5.69), less than Caribou Biosciences, Inc. (7.38), less than Intellia Therapeutics, Inc. (6.73), greater than Sana Biotechnology, Inc. (4.47), less than Reneo Pharmaceuticals, Inc. (57.86), greater than Ginkgo Bioworks Holdings, Inc. (5.79), greater than Ocean Biomedical, Inc. (0.03), greater than Royalty Pharma plc (1.54), greater than Editas Medicine, Inc. (3.75), less than CRISPR Therapeutics AG (21.64), less than Verve Therapeutics, Inc. (13.05), less than Theseus Pharmaceuticals, Inc. (29.93), greater than aTyr Pharma, Inc. (6.07), less than Relay Therapeutics, Inc. (18.42), less than Century Therapeutics, Inc. (10.39), greater than Blueprint Medicines Corporation (3.32),

Build a custom stock screener for Prime Medicine, Inc. (PRME) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prime Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prime Medicine, Inc. (PRME) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prime Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.